Chi‐Chih Hung

3.0k total citations
76 papers, 1.8k citations indexed

About

Chi‐Chih Hung is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Chi‐Chih Hung has authored 76 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Nephrology, 12 papers in Pulmonary and Respiratory Medicine and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Chi‐Chih Hung's work include Chronic Kidney Disease and Diabetes (32 papers), Dialysis and Renal Disease Management (28 papers) and Renal Diseases and Glomerulopathies (13 papers). Chi‐Chih Hung is often cited by papers focused on Chronic Kidney Disease and Diabetes (32 papers), Dialysis and Renal Disease Management (28 papers) and Renal Diseases and Glomerulopathies (13 papers). Chi‐Chih Hung collaborates with scholars based in Taiwan, United States and South Korea. Chi‐Chih Hung's co-authors include Shang‐Jyh Hwang, Hung‐Chun Chen, Yi‐Wen Chiu, Ming‐Yen Lin, Mei‐Chuan Kuo, Jer‐Ming Chang, Yi‐Chun Tsai, Hugo You‐Hsien Lin, Jia‐Jung Lee and Jer‐Chia Tsai and has published in prestigious journals such as PLoS ONE, Scientific Reports and Kidney International.

In The Last Decade

Chi‐Chih Hung

72 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi‐Chih Hung Taiwan 22 935 289 278 227 225 76 1.8k
Filippo Aucella Italy 25 996 1.1× 202 0.7× 271 1.0× 269 1.2× 90 0.4× 143 2.0k
Andrea Galassi Italy 16 693 0.7× 456 1.6× 324 1.2× 309 1.4× 525 2.3× 56 2.0k
Jong Hyun Jhee South Korea 22 625 0.7× 229 0.8× 176 0.6× 173 0.8× 115 0.5× 100 1.4k
Tibor Fülöp United States 22 681 0.7× 359 1.2× 168 0.6× 337 1.5× 146 0.6× 131 1.7k
Maurizio Postorino Italy 23 930 1.0× 367 1.3× 184 0.7× 361 1.6× 148 0.7× 77 1.8k
Carlo Garofalo Italy 25 993 1.1× 502 1.7× 181 0.7× 341 1.5× 415 1.8× 87 2.1k
Marit D. Solbu Norway 28 1.3k 1.4× 545 1.9× 261 0.9× 273 1.2× 367 1.6× 67 2.1k
Gültekin Süleymanlar Türkiye 26 746 0.8× 480 1.7× 234 0.8× 480 2.1× 136 0.6× 128 2.3k
Matthew A. Roberts Australia 26 1.0k 1.1× 718 2.5× 153 0.6× 365 1.6× 239 1.1× 79 2.3k
Dimitrie Siriopol Romania 27 969 1.0× 402 1.4× 150 0.5× 740 3.3× 202 0.9× 100 2.1k

Countries citing papers authored by Chi‐Chih Hung

Since Specialization
Citations

This map shows the geographic impact of Chi‐Chih Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Chih Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Chih Hung more than expected).

Fields of papers citing papers by Chi‐Chih Hung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Chih Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Chih Hung. The network helps show where Chi‐Chih Hung may publish in the future.

Co-authorship network of co-authors of Chi‐Chih Hung

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Chih Hung. A scholar is included among the top collaborators of Chi‐Chih Hung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Chih Hung. Chi‐Chih Hung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuo, I‐Ching, et al.. (2023). The Association between Iron Deficiency and Renal Outcomes Is Modified by Sex and Anemia in Patients with Chronic Kidney Disease Stage 1–4. Journal of Personalized Medicine. 13(3). 521–521. 1 indexed citations
2.
Lin, Hugo You‐Hsien, Yu-Han Chang, Peir‐In Liang, et al.. (2023). Thiazide and thiazide-like diuretics associated with improved cardiovascular and renal outcomes for chronic kidney disease patients. Annals of the Academy of Medicine Singapore. 52(10). 510–521. 1 indexed citations
3.
Lin, Hugo You‐Hsien, Yu-Han Chang, Peir‐In Liang, et al.. (2023). Thiazide and thiazide-like diuretics are associated with improved cardiovascular and renal outcomes in patients with chronic kidney disease. Annals of the Academy of Medicine Singapore. 52(10 - Correct DOI). 510–521. 1 indexed citations
4.
Chang, Kai‐Ting, Hsuan‐Fu Kuo, Sheng‐Wen Niu, et al.. (2023). Association between the risk of heart failure hospitalization and end-stage renal disease with digoxin usage in patients with cardiorenal syndrome: A population-based study. Frontiers in Public Health. 10. 1074017–1074017. 2 indexed citations
5.
Lin, Hugo You‐Hsien, Wei‐Chung Tsai, I‐Ching Kuo, et al.. (2023). Non-insulin-based insulin resistance indices for predicting all-cause mortality and renal outcomes in patients with stage 1–4 chronic kidney disease: another paradox. Frontiers in Nutrition. 10. 1136284–1136284. 12 indexed citations
6.
Niu, Sheng‐Wen, Chien‐Hsing Wu, Hung‐Chun Chen, et al.. (2023). Proteins Secreted by Lung Cancer Cells Induce the Onset of Proteinuria via Focal Adhesion Kinase Signaling in Mice. Laboratory Investigation. 103(8). 100156–100156. 1 indexed citations
7.
Niu, Sheng‐Wen, Hugo You‐Hsien Lin, I‐Ching Kuo, et al.. (2022). Hyperuricemia, a Non-Independent Component of Metabolic Syndrome, Only Predicts Renal Outcome in Chronic Kidney Disease Patients without Metabolic Syndrome or Diabetes. Biomedicines. 10(7). 1719–1719. 1 indexed citations
8.
Zhen, Yen‐Yi, Chien‐Hsing Wu, Hung‐Chun Chen, et al.. (2022). Coordination of LMO7 with FAK Signaling Sustains Epithelial Integrity in Renal Epithelia Exposed to Osmotic Pressure. Cells. 11(23). 3805–3805. 1 indexed citations
9.
Hung, Chi‐Chih, et al.. (2022). UMOD Mutations in Chronic Kidney Disease in Taiwan. Biomedicines. 10(9). 2265–2265. 1 indexed citations
10.
Niu, Sheng‐Wen, Chi‐Chih Hung, Hugo You‐Hsien Lin, et al.. (2022). Reduced Incidence of Stroke in Patients with Gout Using Benzbromarone. Journal of Personalized Medicine. 12(1). 28–28. 7 indexed citations
11.
Chao, Fang‐Lin, I‐Ching Kuo, Sheng‐Wen Niu, et al.. (2022). High Ultrafiltration Rate Is Associated with Increased All-Cause Mortality in Incident Hemodialysis Patients with a High Cardiothoracic Ratio. Journal of Personalized Medicine. 12(12). 2059–2059.
12.
Hung, Chi‐Chih, Yen‐Yi Zhen, Sheng‐Wen Niu, et al.. (2022). Predictive Value of HbA1c and Metabolic Syndrome for Renal Outcome in Non-Diabetic CKD Stage 1–4 Patients. Biomedicines. 10(8). 1858–1858. 5 indexed citations
13.
Kuo, I‐Ching, Ping‐Hsun Wu, Hugo You‐Hsien Lin, et al.. (2019). The association of adiponectin with metabolic syndrome and clinical outcome in patients with non-diabetic chronic kidney disease. PLoS ONE. 14(7). e0220158–e0220158. 23 indexed citations
14.
Kuo, I‐Ching, Hugo You‐Hsien Lin, Sheng‐Wen Niu, et al.. (2018). Anemia modifies the prognostic value of glycated hemoglobin in patients with diabetic chronic kidney disease. PLoS ONE. 13(6). e0199378–e0199378. 21 indexed citations
15.
Hwang, Shang‐Jyh, et al.. (2017). Correlations of dietary energy and protein intakes with renal function impairment in chronic kidney disease patients with or without diabetes. The Kaohsiung Journal of Medical Sciences. 33(5). 252–259. 8 indexed citations
16.
Lin, Hugo You‐Hsien, Kai‐Ting Chang, Yu-Han Chang, et al.. (2016). Nonapnea Sleep Disorders and the Risk of Acute Kidney Injury. Medicine. 95(11). e3067–e3067. 6 indexed citations
17.
Hung, Chi‐Chih, Meili Yang, Ming‐Yen Lin, et al.. (2014). Dipyridamole treatment is associated with improved renal outcome and patient survival in advanced chronic kidney disease. The Kaohsiung Journal of Medical Sciences. 30(12). 599–607. 8 indexed citations
18.
Lee, Jia‐Jung, Ming‐Yen Lin, Jung‐San Chang, et al.. (2014). Hepatitis C Virus Infection Increases Risk of Developing End-Stage Renal Disease Using Competing Risk Analysis. PLoS ONE. 9(6). e100790–e100790. 83 indexed citations
19.
Lin, Hugo You‐Hsien, SC Lee, Sheng‐Fung Lin, et al.. (2013). Urinary neutrophil gelatinase‐associated lipocalin levels predict cisplatin‐induced acute kidney injury better than albuminuria or urinary cystatin C levels. The Kaohsiung Journal of Medical Sciences. 29(6). 304–311. 38 indexed citations
20.
Tsai, Yi‐Chun, et al.. (2009). Quality of life predicts risks of end-stage renal disease and mortality in patients with chronic kidney disease. Nephrology Dialysis Transplantation. 25(5). 1621–1626. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026